Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Lactic acid (Dermacid), LACTIC ACID(ND), Lactic acid (Dermacyd Femina), Lactic Acid (Dermacyd PH_DETINLYN Tangerine Mix), Lactic acid (Dermacyd Femina Delicata), Lactic Acid (Dermacyd PH_DETINBACK Tangerine Mix), Lactacyd Radiance
Lactic Acid · 37 trials · 2 indications
Patient's questionnaire will be completed at V1, V2 and V4. Reduction of vaginal odor, increase in the moisture area, and perception about some items like foam, facility of rinsing, final touch of the mucosa, final fragrance, and cleaning sensation will be rated on a 5-point scale.
| Arm | Type | Description |
|---|---|---|
| Dermacyd (different fragrances) | EXPERIMENTAL | Day 1 until 30: Investigational Product (Dermacyd) Day 31 until 37: wash-out Day 38 until 67: Glycerine Vegetal Soap Granado Traditional |
| Glycerine Vegetal Soap Granado Traditional | ACTIVE_COMPARATOR | Day 1 until 30: Glycerine Vegetal Soap Granado Traditional Day 31 until 37: wash-out Day 38 until 67: Investigational Product (Dermacyd) |
| Dermacyd Silver Frutal (Lactic Acid) | EXPERIMENTAL | Dermacyd Silver Frutal (Lactic Acid) sample will be applied like a curative. Physiologic solution and mineral oil will be also used as a control sample. |
| Dermacyd PH_DESILSTY_FR (Lactic Acid) | EXPERIMENTAL | Dermacyd PH\_DESILSTY\_FR (Lactic Acid) sample will be applied like a curative. Physiologic solution and mineral oil will be also used as a control sample. |
| Dermacyd PH_DESILSTY_FL (Lactic Acid) | EXPERIMENTAL | Dermacyd PH\_DESILSTY\_FL (Lactic Acid) sample will be applied like a curative. Physiologic solution and mineral oil will be also used as a control sample |
| Dermacyd Silver Floral (Lactic Acid) | EXPERIMENTAL | Dermacyd Silver Floral (Lactic Acid) sample will be applied like a curative. Physiologic solution and mineral oil will be also used as a control sample. |
| 1 | EXPERIMENTAL | Lactic Acid (Dermacyd Femina) |
| I | EXPERIMENTAL | - |
| 2 | PLACEBO_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| LACTIC ACID (Dermacid) | DRUG | Route of administration: local |
| Glycerine Vegetal Soap Granado Traditional | DRUG | Route of administration: local |
| LACTIC ACID(ND) | DRUG | Dermacyd Silver Frutal (Lactic Acid) sample will be applied like a curative for 21 consecutive days. |
| Lactic Acid | DRUG | Lactic Acid (Dermacyd Femina) |
| Lactic Acid (Dermacyd PH_DETINBACK Tangerine Mix) | DRUG | Lactic Acid |
| Lactic Acid (Dermacyd PH_DETINLYN Tangerine Mix) | DRUG | Lactic Acid (Dermacyd PH\_DETINLYN Tangerine Mix) |
| Lactic acid (Dermacyd Femina) | DRUG | - |
| Lactic acid (Dermacyd Femina Delicata) | DRUG | - |
| Distilled water | OTHER | Application of patches containing distilled water for 24 hours |
Inclusion criteria: * Perfect mucosa in the product analysis region * Volunteers with active sexual life: normal Papanicolau test performed less than one year is mandatory * Bacterioscopy describing the vaginal flora * Negative Trichomonas vaginalis test * Negative Whiff test * Willingness in using...
Lactic Acid is a small molecule developed by Sanofi under the Dermacyd line of hygiene products. It has been studied in Phase 3 trials focused on hygiene and odor reduction, including a completed study of 230 women in Brazil. It is not described as a treatment for a specific disease indication.
Lactic Acid has been evaluated for hygiene and odor reduction in Phase 3 clinical trials. The completed studies enrolled healthy volunteers, primarily women aged 18 and older, in Brazil. The specific medical indication is not publicly disclosed, and the trials centered on hygiene-related endpoints.
Sanofi, which trades under the ticker SNY, is the developer of Lactic Acid. The drug is studied under the Dermacyd brand family, and Sanofi has sponsored the completed Phase 3 trials registered for this asset.
Lactic Acid has completed Phase 3 clinical development. All 37 registered trials are completed, with no active trials currently listed. The Phase 3 studies were placebo-controlled and randomized, and enrolled a total of 1,717 participants across the program.
Lactic Acid has 37 completed clinical trials, including NCT01158365, a Phase 3 odor-reducing study of 230 women in Brazil, and NCT00933946, NCT00933907, and NCT00933842, which were Phase 3 compatibility and photo-evaluation studies of 55, 55, and 27 participants respectively.
Yes, Lactic Acid is also known as Dermacid and Dermacyd Femina, along with related names such as Dermacyd Femina Delicata and Dermacyd PH_DETINBACK Tangerine Mix. These are alternative names for the same Sanofi asset studied in the Dermacyd hygiene trials.